Notice Concerning Revisions to Full-Year Consolidated Financial Guidance for Fiscal Year Ending March 31, 2027 (FY2026)8/7 15:30TDnetPDF(183KB)
Consolidated Financial Results for the Three Months Ended June 30, 2026〔IFRS〕8/7 15:30TDnetPDF(258KB)
Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants)8/4 18:35TDnetPDF(113KB)
Notice Concerning Completion of Disposal of Treasury Shares as Restricted Stock Remuneration8/4 18:25TDnetPDF(116KB)
Notice Regarding Disposal of Treasury Shares as Restricted Stock Remuneration7/16 15:00TDnetPDF(183KB)
Other Matters Subject to the Electronic Provision Measures 2026 Annual General Meeting6/2 8:00TDnetPDF(1MB)
Consolidated Financial Results for the Fiscal Year Ended March 31, 2026〔IFRS〕5/15 15:30TDnetPDF(486KB)
Consolidated Financial Results for the Nine Months Ended December 31, 2025〔IFRS〕2/13 15:30TDnetPDF(261KB)
Notice Concerning Revisions to Full-Year Financial Guidance for Fiscal Year Ending March 31, 2026 (FY2025)2025/11/12TDnetPDF(157KB)
Consolidated Financial Results for the Six Months Ended September 30, 2025〔IFRS〕2025/11/12TDnetPDF(256KB)
Terumo to acquire OrganOx Limited, a leading innovator in organ preservation devices, marking strategic entry into the organ transplantation-related2025/8/25TDnetPDF(225KB)